Signup for PPM

Meeting Highlights from ACR Convergence 2020

Meeting Information

November 5-9, 2020

Virtual

The American College of Rheumatology's annual meeting was held virtually in November 2020. #ACR20

From this Meeting:

ACR Releases Updated Draft Guidelines for Juvenile Idiopathic Arthritis (JIA)

New disease-modifying biologics (DMARDs) and evidence regarding steroids, immunizations, and infection screening have led to a need for updated treatment approaches for juvenile idiopathic arthritis (JIA).

Debate: When Methotrexate Fails – The Use of JAK or TNF Inhibitors

Vibeke Strand, MD, and Michael E. Weinblatt, MD, make distinct cases for the use of JAK inhibitors versus TNF inhibitors for the treatment of rheumatoid arthritis in patients refractory to methotrexate.

Pharmacotherapy & Rheumatic Disease in Older Adults

Experts discuss pharmacotherapy tactics for treating rheumatic disease, including rheumatoid arthritis, in older adults.

Rheumatoid Disease Therapy and Immunological Complications

Immunological complications of rheumatoid arthritis therapy can make clinical decisions around treatment more difficult. In an ACR 2020 Convergence panel, experts reviewed inflammatory arthritis in the context of immune checkpoint inhibitors, including a look at the safety of the recombinant zoster (shingles) vaccine and cancer tumor response in patients with rheumatic disease.

When Rheumatoid Arthritis Treatment Gets Difficult: 3 Cases Offer Potential Solutions

Rheumatoid arthritis now has many treatment options, allowing providers to tailor therapy to individual patients. However, when patients have chronic comorbidities on top of the disease, or when therapy after therapy fails, decisions about treatment and monitoring can be complex. 3 case examples.

This site complies with the HONcode standard for trustworthy health information.

Remedy Health Media, LLC does not, by publication of the advertisements contained herein, express endorsement or verify the accuracy and effectiveness of the products and claims contained therein. Remedy Health Media, LLC disclaims any liability for damages resulting from the use of any product advertised herein and suggests that readers fully investigate the products and claims prior to purchasing. The views of the authors are not necessarily those of Remedy Health Media, LLC.

Practical Pain Management is sent without charge 6 times per year to pain management clinicians in the US.

Use of this website is conditional upon your acceptance of our user agreement.

close X

Meeting Highlights from ACR Convergence 2020

Meeting Information

From this Meeting:

Subscribe to "Pain Monitor", a PPM eNewsletter for HCPs